FDA to review Regenxbio’s gene therapy BLA for Hunter syndrome

The IDS gene delivery within CNS cells offers a permanent source of secreted iduronate-2-sulfatase protein, capable of crossing the blood-brain barrier. Credit: Robina Weermeijer on Unsplash.



  • FDA to review Regenxbio's gene therapy BLA for Hunter syndrome